SCHEMBL14601915

SCHEMBL14601915

CN1CC[C@H](N[SH](=O)=O)C1=O

nearest known ligand 0.37

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.32
HPGDS O60760 1/20 0.32
SCN9A Q15858 1/20 0.31
APOL1 O14791 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6338704 0.77
SCHEMBL19559437 0.77
SCHEMBL24777625 0.72 HPGDS (0.32) HPGDS
SCHEMBL25106080 0.72 HPGDS (0.32) HPGDS
SCHEMBL21134428 0.72 ADH1B (0.37) HPGDS
SCHEMBL23270649 0.72 IDH1 (0.35) HPGDS
SCHEMBL25106076 0.72 HPGDS (0.32) HPGDS
SCHEMBL9963368 0.72 MAPK1 (0.36) MAPK1HPGDS
SCHEMBL6385322 0.71 HPGDS (0.41) MAPK1HPGDSSCN9AAPOL1
SCHEMBL15998895 0.71 HPGDS (0.41) MAPK1HPGDSSCN9AAPOL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7157470-B2 Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2007-01-02 US disclosed